🇺🇸 Atorvastatin 10 mg in United States

94 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Myalgia — 14 reports (14.89%)
  2. Death — 11 reports (11.7%)
  3. Nausea — 11 reports (11.7%)
  4. Dizziness — 10 reports (10.64%)
  5. Fatigue — 10 reports (10.64%)
  6. Muscular Weakness — 9 reports (9.57%)
  7. Acute Kidney Injury — 8 reports (8.51%)
  8. Dyspnoea — 7 reports (7.45%)
  9. Gait Disturbance — 7 reports (7.45%)
  10. Muscle Spasms — 7 reports (7.45%)

Source database →

Atorvastatin 10 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Atorvastatin 10 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Atorvastatin 10 mg in United States?

Organon and Co is the originator. The local marketing authorisation holder may differ — check the official source linked above.